Spectral Medical Provides October Tigris Trial Update
Dr. John Kellum, Chief Medical Officer of Spectral, noted, “Despite a lower enrollment rate for October we continue to see strong performance across trial sites for screening. Our sites are eager to ...
Spectral Medical Announces Third Quarter Results and Provides Corporate Update
Tigris Trial Enrollment at 135 PatientsStrengthened Balance Sheet with Expected Funds to Complete Tigris Trial EnrollmentTORONTO, Nov. 08, 2024 ...
EurekAlert!23d
Tire-wear particles pose health risks to aquatic organisms
These changes were accompanied by disruptions in the gut microbiota, with a notable increase in Proteobacteria, a major source of gut-derived endotoxic lipopolysaccharide (LPS). Such disruptions ...
Financial Post1mon
Spectral Medical Provides September Tigris Trial Update
In July 2022, the U.S. FDA granted Breakthrough Device Designation for PMX for the treatment of endotoxic septic shock. Approximately 330,000 patients are diagnosed with septic shock in North America ...
Spectral Medical Inc.: Spectral Medical Announces Third Quarter Results and Provides Corporate Update
Tigris Trial Enrollment at 135 PatientsStrengthened Balance Sheet with Expected Funds to Complete Tigris Trial Enrollment TORONTO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" ...